$0.000001
0.000.00%
At close: -
Eloxx Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eloxx Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-13 | $-1.31 | $-1.97 | 33.5 % |
Jun 2023 | 2023-08-14 | $-1.96 | $-1.54 | -27.3 % |
Mar 2023 | 2023-05-15 | $-2.88 | $-2.55 | -12.9 % |
Mar 2023 | 2023-04-03 | $-2.92 | $-2.97 | 1.68 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2023 | 2023-05-15 | $0 | $700.00K | -100.0 % |
Jun 2022 | 2022-08-15 | $0 | $2.33M | -100.0 % |
Mar 2022 | 2022-05-10 | $0 | $3.50M | -100.0 % |
Eloxx Pharmaceuticals (ELOX) is scheduled to report earnings on January 3, 2025. The last reported earnings were for reported on November 13, 2023 for Q3.
The Actual EPS was $-1.31, which beat the estimate of $-1.97.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.